Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Beta-Thalassemia
Related studies linked through entity extraction aliases.
A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada
- Status
- COMPLETED
- Phase
- NA
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- Status
- RECRUITING
- Phase
- PHASE3
Assessment of Cognitive Function, Fatigue and Health Related Quality of Life in Children With Beta Thalassemia
- Status
- COMPLETED
- Phase
- N/A
The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Prevelence of HBB c.93-21 G-A in β Thalassemia Patients
- Status
- UNKNOWN
- Phase
- N/A
Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)
- Status
- COMPLETED
- Phase
- N/A
Iron Status in BTM With Blood Transfusion
- Status
- UNKNOWN
- Phase
- N/A
Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia
- Status
- COMPLETED
- Phase
- PHASE2
Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (THALA-RAP)
- Status
- UNKNOWN
- Phase
- PHASE2
Thrombophilia In Beta Thalassemia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Long-term Follow-up Study in Participants Who Received CTX001
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
- Status
- RECRUITING
- Phase
- PHASE2
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- Status
- RECRUITING
- Phase
- PHASE2
Choroidal Thickness in Beta-thalassemia Patients
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Status
- RECRUITING
- Phase
- PHASE3
Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus
- Status
- COMPLETED
- Phase
- PHASE4